AFM and metabolic dysfunction-associated steatotic liver disease: Higher afamin levels at KORA F4 (baseline) were associated with higher increases in NAFLD LFS between KORA F4 and FF4 at all levels of adjustment (all p < .001), whereas there were no significant associations with HSI in any model (all p > .05).